(19)
(11) EP 0 975 628 A1

(12)

(43) Date of publication:
02.02.2000 Bulletin 2000/05

(21) Application number: 98915368.9

(22) Date of filing: 07.04.1998
(51) International Patent Classification (IPC)7C07D 409/12, A61K 31/535, A61K 31/38
(86) International application number:
PCT/US9806/989
(87) International publication number:
WO 9845/286 (15.10.1998 Gazette 1998/41)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
Designated Extension States:
AL LT LV RO SI

(30) Priority: 09.04.1997 US 43118 P

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, Indiana 46285 (US)

(72) Inventor:
  • GLASEBROOK, Andrew, Lawrence
    Zionsville, IN 46077 (US)

(74) Representative: Denholm, Anna Marie et al
Eli Lilly and Company Limited,Lilly Research Center,Erl Wood Manor
Windlesham,Surrey GU20 6PH
Windlesham,Surrey GU20 6PH (GB)

   


(54) PREVENTION OF BREAST CANCER WITH SELECTIVE ESTROGEN RECEPTOR MODULATORS